Novel Immunochromatography Assay Based on Background Fluorescence Quenching for the Sensitive Determination of Serum Cystatin C

References

• Abrahamson, M., I. Olafsson, A. Palsdottir, M. Ulvsbäck, Å. Lundwall, O. Jensson, and A. Grubb. 1990. Structure and expression of the human cystatin C gene. Biochemical Journal 268(2):287–94. doi:10.1042/bj2680287
   PubMed Web of Science ®Google Scholar
• Aceti, A., A. Pennica, D. Celestino, S. B. Paparo, M. Caferro, S. Sanguigni, M. Marangi, and A. Sebastiani. 1988. A new serological technique, time-resolved fluoroimmunoassay (TRFIA), for the immunological diagnosis of urinary schistosomiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 82(3):445–7.
   PubMed Web of Science ®Google Scholar
• Chen, X., Y. Xu, J. Yu, J. Li, X. Zhou, C. Wu, Q. Ji, Y. Ren, L. Wang, Z. Huang, et al. 2014. Antigen detection based on background fluorescence quenching immunochromatographic assay. Analytica Chimica Acta 841:44–50. doi:10.1016/j.aca.2014.07.025
   PubMed Web of Science ®Google Scholar
• Clausen, J. 1961. Protein in normal cerebrospinal fluid not found in serum. Proceedings of the Society for Experimental Biology and Medicine 107(1):170–2. doi:10.3181/00379727-107-26569
   PubMed Web of Science ®Google Scholar
• Damm, T. 2014. Development of a cystatin C-specific bioassay for integration into an implantable biochip system. Diss. Dissertation, RWTH Aachen.
   Google Scholar
• Duan, N., S. J. Wu, X. Y. Ma, X. J. Chen, Y. K. Huang, and Z. P. Wang. 2012. Gold nanoparticle-based fluorescence resonance energy transfer aptasensor for ochratoxin a detection. Analytical Letters 45(7):714–72. doi:10.1080/00032719.2011.653899
   Web of Science ®Google Scholar
• Finney, H., D. J. Newman, W. Gruber, P. Merle, and C. P. Price. 1997. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clinical Chemistry 43(6):1016–22.
   PubMed Web of Science ®Google Scholar
• Gerhardt, T., U. Poge, B. Stoffel-Wagner, M. Ahrendt, M. Wolff, U. Spengler, H. Palmedo, T. Sauerbruch, and R. P. Woitas. 2006. Estimation of glomerular filtration rates after orthotopic liver transplantation: Evaluation of cystatin C-based equations. Liver Transplantation 12(11):1667–72. doi:10.1002/lt.20881
   PubMed Web of Science ®Google Scholar
• Huerta, A., B. López, S. Ravassa, G. S. José, R. Querejeta, Ó. Beloqui, E. Zubillaga, G. Rábago, C. Brugnolaro, J. Díez, et al. 2016. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism. Journal of Hypertension 34(1):130–8. doi:10.1097/HJH.0000000000000757
   PubMed Web of Science ®Google Scholar
• Kobayashi, T., H. Yokokawa, K. Fujibayashi, T. Haniu, T. Hisaoka, H. Fukuda, and T. Naito. 2017. Association between high cystatin C levels and carotid atherosclerosis. World Journal of Cardiology 9(2):174–81. doi:10.4330/wjc.v9.i2.174
   PubMed Web of Science ®Google Scholar
• Kumar, K., A. Mishra, A. A. Sheikh, P. Patel, R. Bhagat, and U. Maibam. 2017. Cystatin C as a marker and its clinical importance. The Pharma Innovation Journal 6(11):467–70.
   Google Scholar
• Odutayo, A., and D. Cherney. 2012. Cystatin C and acute changes in glomerular filtration rate. Clinical Nephrology 78(7):64–75. doi:10.5414/CN107324
   PubMedGoogle Scholar
• Pergande, M., and K. Jung. 1993. Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodies. Clinical Chemistry 39(9):1885–90.
   PubMed Web of Science ®Google Scholar
• Poulik, M. D., D. J. Perry, E. Vokac, and T. Sekine. 1983. Post-gamma globulin. II. Radioimmunoassay determination of levels of post-gamma globulin and β2-microglobulin. Clinica Chimica Acta 128(2–3):249–60. doi:10.1016/0009-8981(83)90325-X
   PubMed Web of Science ®Google Scholar
• Shlipak, M. G., M. J. Sarnak, R. Katz, L. F. Fried, S. L. Seliger, A. B. Newman, D. S. Sis-Covick, and C. Stehman-Breen. 2005. CystatinC and the risk of death and cardiovascular events among elderly persons. The New England Journal of Medicine 352:2049–60.
   PubMed Web of Science ®Google Scholar
• Takeuchi, M., Y. Fukuda, I. Nakano, Y. Katano, and T. Hayakawa. 2001. Elevation of serum cystatin C concentrations in patients with chronic liver disease. European Journal of Gastroenterology & Hepatology 13(8):951–5. doi:10.1097/00042737-200108000-00013
   PubMed Web of Science ®Google Scholar
• Tang, W. H. W., F. Van Lente, K. Shrestha, R. W. Troughton, G. S. Francis, W. Tong, M. G. Martin, A. G. Borowski, S. Jasper, R. C. Starling, et al. 2008. Impact of myocardial function on cystatinC measurements in chronic systolic heart failure. Journal of Cardiac Failure 14(5):394–9. doi:10.1016/j.cardfail.2008.01.006
   PubMed Web of Science ®Google Scholar
• Tavera, C., J. Leung-Tack, D. Prevot, M. C. Gensac, J. Martinez, P. Fulcrand, and A. Colle. 1992. Cystatin C secretion by rat glomerular mesangial cells: autocrine loop for in vitro growth-promoting activity. Biochemical and Biophysical Research Communications 182(3):1082–8.
   PubMed Web of Science ®Google Scholar
• Uchida, K., and A. Gotoh. 2002. Measurement of cystatin-C and creatinine in urine. Clinica Chimica Acta 323(1–2):121–8. doi:10.1016/S0009-8981(02)00177-8
   PubMed Web of Science ®Google Scholar
• Visvardis, G., I. Griveas, R. Zilidou, D. Papadopoulou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, A. Pavlitou, et al. 2004. Glomerular filtration rate estimation in renal transplant patients based on serum Cystatin-C levels: Comparison with other markers of glomerular filtration rate. Transplantation Proceedings 36(6):1757–9. doi:10.1016/j.transproceed.2004.06.009
   PubMed Web of Science ®Google Scholar
• Westhuyzen, J. 2006. Cystatin C: A promising marker and predictor of impaired renal function. Annals of Clinical & Laboratory Science 36:387–94. doi:10.1056/NEJMoa043161
   PubMed Web of Science ®Google Scholar
• Yang, S., J. Cai, R. Lu, J. Wu, M. Zhang, and X. J. Zhou. 2017. Association between serum cystatin C level and total magnetic resonance imaging burden of cerebral small vessel disease in patients with acute lacunar stroke. The Journal of Stroke & Cerebrovascular Diseases 26(1):186–91. doi:10.1016/j.jstrokecerebrovasdis.2016.09.007
   PubMed Web of Science ®Google Scholar
• Yassine, H. N., O. Trenchevska, Z. Dong, Y. Bashawri, J. Koska, P. D. Reaven, R. W. Nelson, and D. Nedelkov. 2016. The association of plasma cystatin C proteoforms with diabetic chronic kidney disease. Journal of Proteome Research 14(1):7. doi:10.1186/s12953-016-0096-7
   Google Scholar
• Zhang, Y., and L. Sun. 2017. Cystatin C in cerebrovascular disorders. Current Neurovascular Research 14(4):406–14. doi:10.2174/1567202614666171116102504
   PubMed Web of Science ®Google Scholar
• Zivlas, C., F. Triposkiadis, S. Psarras, G. Giamouzis, I. Skoularigis, S. Chryssanthopoulos, and D. Cokkinos. 2018. Cystatin C and galectin-3 as therapeutic targets in heart failure. Therapeutic Advances in Cardiovascular Disease 12(8):233–235. 1753944718778470.
   PubMedGoogle Scholar